SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study

Clinical trial NCT00522951 · COMPLETED

Trial details

NCT number: NCT00522951
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Brain Metastases

Start date: 2007-08-01
Primary completion: 2008-08-01
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.